SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-21-008080
Filing Date
2021-02-10
Accepted
2021-02-10 16:57:55
Documents
6
Period of Report
2021-03-10

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT ea135083-pre14a_silopharma.htm PRE 14A 477841
2 GRAPHIC proxy_001.jpg GRAPHIC 9096
3 GRAPHIC proxy_002.jpg GRAPHIC 2194
4 GRAPHIC proxy_003.jpg GRAPHIC 1732
5 GRAPHIC proxy_004.jpg GRAPHIC 1563
6 GRAPHIC proxy_005.jpg GRAPHIC 2774
  Complete submission text file 0001213900-21-008080.txt   503792
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-54872 | Film No.: 21614828
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl